NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells (2022)
- Authors:
- USP affiliated authors: MACHADO NETO, JOÃO AGOSTINHO - ICB ; CARVALHO, MARIA FERNANDA LOPES - ICB ; MIRANDA, LÍVIA BASSANI LINS DE - ICB ; SILVA, JEAN CARLOS LIPRERI DA - ICB
- Unidade: ICB
- DOI: 10.1007/s10637-022-01249-z
- Subjects: FARMACOLOGIA; ANTINEOPLÁSICOS; CÉLULAS CULTIVADAS DE TUMOR; NEOPLASIAS PANCREÁTICAS; COMPOSTOS AROMÁTICOS; CITOESQUELETO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Investigational New Drugs
- ISSN: 1573-0646
- Volume/Número/Paginação/Ano: p. 1-10, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SILVA, Jean Carlos Lipreri da et al. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells. Investigational New Drugs, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10637-022-01249-z. Acesso em: 26 jan. 2026. -
APA
Silva, J. C. L. da, Carvalho, M. F. L., Miranda, L. B. L. D., Almeida, B. O. de, Lima, K., & Machado Neto, J. A. (2022). NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells. Investigational New Drugs, 1-10. doi:10.1007/s10637-022-01249-z -
NLM
Silva JCL da, Carvalho MFL, Miranda LBLD, Almeida BO de, Lima K, Machado Neto JA. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells [Internet]. Investigational New Drugs. 2022 ; 1-10.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1007/s10637-022-01249-z -
Vancouver
Silva JCL da, Carvalho MFL, Miranda LBLD, Almeida BO de, Lima K, Machado Neto JA. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells [Internet]. Investigational New Drugs. 2022 ; 1-10.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1007/s10637-022-01249-z - Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes
- Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells
- Investigação da inibição de ezrina como potencial alvo farmacológico em neoplasias hematológicas
- Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia
- Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia
- New molecular targets in acute leukemias: cytoskeletal regulatory proteins
- NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells
- Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia
- Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells
- Targeting glioma cells by antineoplastic activity of reversine
Informações sobre o DOI: 10.1007/s10637-022-01249-z (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
